BioCentury
ARTICLE | Company News

Michigan to begin talks with drug manufacturers for value-based deals

November 16, 2018 5:10 PM UTC

With a stamp of approval from CMS on Nov. 14, Michigan joins Oklahoma as one of the only two states with the agency's OK to negotiate Medicaid outcomes-based pricing agreements with drug manufacturers.

"Michigan’s waiver will empower the state to demand results from drug manufacturers in exchange for paying for medicines," CMS Administrator Seema Verma said in a speech at the Biopharma Congress on Nov. 14...